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ABStrACt: We report the innovation of both a partly-
covered and completely-covered, variable-diameter, balloon-
expandable stent that was custom-designed by NuMed, Inc for 
percutaneous closure of a baffle leak after total caval pulmonary 
connection (TCPC). A 50-year-old patient, born with tricuspid 
atresia, who had undergone TCPC, developed severe persistent 
cyanosis due to a right-to-left shunt through a TCPC baffle leak. 
Re-operation was deemed too high risk. Therefore, considering 
his complex anatomy, a custom-made, partly-covered, tapered, 
balloon-expandable stent was designed and successfully deployed. 
Months later, the shunt recurred at the junction of the covered 
to uncovered stent cells; subsequently, a second fully-covered, 
custom-made, tapered stent was implanted with an excellent out-
come. The use of covered or partly-covered customized variable-
diameter stents for closure of baffle leak after TCPC is feasible 
and resulted in marked clinical improvement. Customized bal-
loon-expandable stents may be superior to traditional cylindrical 
stents because of better anchoring and apposition. 
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Right-to-left shunts after total caval pulmonary connec-
tion (TCPC) surgery may be intentionally left by creating 
a fenestration from the TCPC baffle to the systemic atrium 
to ensure sufficient cardiac output (fenestrated TCPC).1 
However, shunts may arise as a complication caused by baf-
fle dehiscence.2 In both situations, the right-to-left shunt 
may require closure, which may be performed percutane-
ously with atrial septal defect (ASD) occluders, patent duc-
tus arteriorus (PDA) occuders, coils, or covered stents.2-7 
The literature on the use of covered stents in patients 
with complex congenital heart disease is limited8,9 and the 
marked change in diameter of the involved structures can 
hamper the use of cylindrical stents. We describe the use 
of novel, customized, tapered, balloon-expandable covered 
stents for occlusion of a large baffle leak in a patient with 
complex anatomy. 
Methods
Patient. A 50-year-old male patient, born with tricus-
pid atresia, underwent a Glenn procedure (connection of 
the superior vena cava with the right pulmonary artery) in 
childhood and a Blalock-Taussig shunt (connection of the 
subclavian artery to the pulmonary artery) at the age of 20 
years. Later, at the age of 25 years, a fenestrated TCPC was 
performed, using Hemashield grafts. A 5 mm fenestration 
to the systemic atrium was placed in the pericardial baffle. 
Shortly after TCPC surgery, the Hemashield graft to the 
left pulmonary artery occluded and two percutaneous at-
tempts to re-open it were unsuccessful.
After doing clinically well for a number of years, the 
patient developed progressive shortness of breath and cya-
nosis. An angiogram showed a patent Glenn shunt, chronic 
occlusion of the left pulmonary artery, and a large residual 
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Figure 1. Angiographic assessment of baseline anatomy: there is a 
marked change in vessel diameter between the atrial portion of the baffle 
and the connection to the pulmonary artery. Note the occluded left pul-
monary artery.
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shunt from the TCPC to the systemic atrium along the 
superior edge of the pericardial baffle. In addition, the in-
tentionally created 5 mm fenestration was a second source 
of right-to-left shunting. 
Multidisciplinary discussions considered further thera-
peutic options with surgical correction deemed very high 
risk and percutaneous closure of the significant right-to-
left shunt was deemed preferable. 
Anatomical and physiological considerations. On 
echocardiography, the left ventricle was markedly dilated 
with a mildly depressed systolic ejection fraction of 50%. 
The peak gradient across the fenestration was 9 mm Hg. 
The site of the baffle leak appeared to be in the medial as-
pect of the tunnel. The baffle measured 22 mm in diameter 
at the leak site and 11 mm at the attachment to the right 
pulmonary. In order to fully cover the leak and to suffi-
ciently anchor the stent in the right pulmonary artery, a 
total stent length of about 60 mm was required (Figure 1).
Effective percutaneous closure was felt to require a 
partly-covered custom stent design to secure reliable place-
ment and anchoring given the marked change in diameter 
between the actual baffle and the right pulmonary artery. 
Since the only source of blood supply to the lungs was the 
right pulmonary artery, it was crucial not to compromise 
flow into the right pulmonary artery. 
Stent and delivery system design. In collaboration 
with the company engineers, the stent design was based 
on a modified covered Cheatham Platinum (CP) stent 
(NuMed Inc). The CP was an expandable polytetrafluo-
roethylene (ePTFE) covered stent, with a 90% platinum 
and 10% iridium frame and a strut thickness of 0.013˝. 
The stent configuration consisted of 10 strut cells, allow-
ing expansion up to 30 mm. The novelty of this system was 
the balloon-in-balloon delivery catheter (NuMed Inc). The 
inner balloon measured 6 cm x 8 mm and the outer bal-
loon was asymmetrical with the cranial 2.5 cm of the outer 
balloon expanding to 16 mm (2.5 cm x 16 mm) when fully 
inflated and the caudal 4 cm expanding to 22 mm (4 cm 
x 22 mm). The ePTFE covered only the caudal 40 mm of 
the stent. As this stent expands, it progressively shortens; 
hence, it is necessary to accommodate greater shortening 
of the larger diameter portion of the stent (anticipated to 
be 15%) than at the smaller distal part of the stent. Infla-
tion of the inner balloon would lead to partial expansion 
and anchoring in the narrower cranial portion. This would 
result in minimal ability to adjust the position prior to in-
flation of the outer balloon for final deployment.
Procedure. The procedure was performed in the cath-
eterization laboratory under general anesthesia and trans-
esophageal echocardiographic imaging. Right femoral (18 
Figure 2. Snaring of the Amplatz extra-stiff wire from the jugular access site.
Figure 3. (A) Positioning of the stent. (B) Inflation of the inner bal-
loon allowing final positioning. (C) Inflation of the asymmetrical outer 
balloon with a bigger diameter at the caudal 4 cm and smaller diameter at 
the cranial 2.5 cm. (D) Postdilation of the caudal (not shown) and the 
cranial part of the stent in order to achieve approximately 20% oversizing.
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Fr, Cook Canada, Inc) and jugular venous (8 Fr) and left femo-
ral arterial (5 Fr for pressure recording) accesses were obtained.
An Amplatz extra-stiff wire was introduced from the 
femoral vein and snared (35 mm loop Gooseneck snare; 
eV3, Inc) from the jugular access site as previously de-
scribed2 (Figure 2). The endovascular stent and delivery 
system were inserted via the 18 Fr sheath and positioned to 
accommodate the anticipated shortening. Positioning was 
guided by contrast injections through the jugular sheath 
(Figure 3A) and after partial inflation of the inner balloon 
(Figure 3B) the position was adjusted and the stent was 
fully deployed by inflating the outer balloon (Figure 3C). 
Postdilatations were performed using a 25 mm Nucleus 
balloon (NuMed, Inc) for the caudal part of the stent and 
an 18 mm Z-med balloon (NuMed, Inc) for the cranial 
part of the stent (Figure 3D).
results
Despite aggressive postdilation, a small residual shunt 
at the baffle leak persisted. Therefore, we decide to occlude 
the intentional TCPC fenestration with a 5 mm ASD oc-
cluder (AGA Medical Corporation; Figure 4). The final 
stent dimensions were slightly oversized by approximately 
20% as compared to the baseline measurements (Table 
1 and Figure 4). Procedural success was documented by 
marked reduction in right-to-left shunt and an increase in 
arterial blood saturation (preprocedural 76%, postproce-
dural 95%). Venous and arterial sheaths were removed and 
entry sites manually compressed. There were no procedural 
complications and the patient was discharged the follow-
ing morning. He was given aspirin and clopidogrel for 3 
months in addition to chronic warfarin therapy. 
Despite initial clinical improvement, the patient pre-
sented 1 month later with worsening dyspnea. His oxygen 
saturations had again gone down to 83%. Venograms of 
the TCPC and superior vena cava showed a recurrent leak 
around the transition of the covered to the uncovered por-
tion of the stent, causing recurrence of a clinically signifi-
cant right-to-left shunt (Figure 5). It was felt that a second 
Figure 4. The stent is well expanded and safely anchored in the pulmonary 
artery. The Fontan fenestration is occluded with a 5 mm atrial septal defect 
(ASD) occluder. CP = Cheatham Platinum stent.
Figure 5. Contrast injection in the stent shows the leak at the junction 
from the uncovered to the covered stent cells with a significant shunt to 
the common atrium (white arrow pointing at the contrast outside and 
around the covered stent portion).
Table 1. Baseline measurements and final stent dimensions.
Right PA Common PA Leak site
Baseline first stent 
(mm)
11 12 22
Final dimensions 
first stent (mm)
15 14 26
Oversizing first stent 
(%)
36 16 18
Baseline second 
stent (mm)
14 14 24
Final dimensions 
second stent (mm)
15 14 24
Oversizing second 
stent (%)
7 0 0
PA = pulmonary artery.
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percutaneous procedure placing a fully ePTFE-covered 
stent inside the first stent would exclude the shunt.
Second procedure. Since the first stent in place con-
stituted a radio-opaque landing zone for the second stent, 
there was limited value in transesophageal echocardiogra-
phy guidance and general anesthesia was not used. A sec-
ond modified custom stent with a complete ePTFE covering 
(NuMed, Inc) was produced. It was designed to inflate in 
the larger portion up to 24 mm and in the upper narrower 
portion to 14 mm. The procedure was carried out using an 
approach similar to the first procedure. The initial venogram 
in the Fontan circuit demonstrated immediate flow of con-
trast from the baffle into the systemic atrium (Figure 5). 
We placed the second stent within the preexisting stent in 
the Fontan circuit (Figure 6A). A marker band on the de-
livery catheter aided localization of the transition point in 
the stent diameter. We then sequentially hand inflated the 
balloon-in-balloon device to fully deploy the stent (Figure 
6B). It was very well positioned and measured 15 mm in the 
upper narrower portion and 24 mm in the lower portion. A 
postprocedure venogram demonstrated no contrast from the 
Fontan to the atrium (Figure 7), with transit through the 
lung to the systemic atrium in a delayed fashion as intended. 
The systemic oxygen saturation increased to 97% and the 
patient was discharged home the next morning reporting 
marked improvement in his dyspnea. 
When seen 6 months later, the patient reported con-
tinued improved symptoms (New York Heart Association 
class II). His exercise capacity during cardiopulmonary ex-
ercise testing had considerably improved from 45% of the 
age-predicted maximum preprocedure to 54% at 6 months 
postprocedure.
Discussion
Although freedom from re-operation after TCPC sur-
gery is high,10-12 re-operation in these patients carries a 
high mortality risk.1,3,14 Percutaneous procedures are low-
er-risk alternatives to re-operation, but abrupt changes in 
vessel diameter may hamper a good result for conventional 
cylindrical stents. Self-expanding nitinol stents partly ac-
count for these diameter changes, but at the price of lower 
radial force and greater risk of stent migration compared to 
balloon-expandable stents.15,16
In this case, we used a novel customized stent delivery 
system to better accommodate the marked changes in baffle 
diameter. This new stent and delivery system have the po-
tential for better apposition and anchoring as compared to 
cylindrical stents. The first stent was designed to only cover 
the larger diameter portion to exclude the leak at the dehis-
cence and reduce the risk of placing the covered portion too 
cranial, avoiding obstruction of the right pulmonary artery. 
However, ineffective sealing occurred at the superior bor-
der related to changing diameter and angular configuration 
of the connection to the right Glenn or due to dislocation 
Figure 7. Contrast injection in the stent shows no shunt from the Fon-
tan circulation to the common atrium.
Figure 6. (A) Positioning of the second stent, which is still inside the sheath. 
(B) Deployment of the second stent (both deployment balloons are inflated).For Personal Use. 
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of the ePTFE covering. The second fully-covered stent en-
abled complete exclusion and coverage of the transition zone 
where the stent diameter change was essential. 
Alternative approaches might have been to place a fully-
covered cylindrical stent either initially or on the second 
attempt, anticipating that the smaller diameter portion 
would simply be underexpanded. We chose to avoid a sig-
nificant rupture risk by constructing the stent with vari-
able diameters. A second concern with using a cylindrical 
stent was the potential for caudal displacement, since the 
cranial portion of the balloon would be markedly oversized 
for that portion of the vessel. Other approaches could in-
clude placing 2 separate overlapping stents with different 
diameters at the outset; however, this would add additional 
complexity and have similar challenges in dealing with the 
transition point.    
Conclusions
The use of covered or partly-covered customized ta-
pered stents for closure of baffle leak after TCPC is feasible 
and resulted in marked clinical improvement. Customized 
balloon-expandable stents may provide a good alternative 
to traditional cylindrical stents with potential for better 
anchoring and apposition in complex anatomies. 
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